BGoldsberry
Contributor
Hello,
I was wondering if anyone has experience using the Morphology of Neoplasm codes for billing purposes. Can they/should they be used for Part B claims? How are they used and reported on a HCFA? And lastly, will they be obsolete with the implementation of ICD-10?
I have been trying to find a clear set of guidelines to follow but I haven't found it yet. Any help would be appreciated.
Thank you.
I was wondering if anyone has experience using the Morphology of Neoplasm codes for billing purposes. Can they/should they be used for Part B claims? How are they used and reported on a HCFA? And lastly, will they be obsolete with the implementation of ICD-10?
I have been trying to find a clear set of guidelines to follow but I haven't found it yet. Any help would be appreciated.
Thank you.